CV Sciences, Inc. Total Revenue

Quick Answer

CV Sciences, Inc. reported Total Revenue of $13.79 million for the year ending 2025.

  • CV Sciences, Inc. showed a decrease of -12.2% in Total Revenue from 2024 to 2025.
  • This data is from CV Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2013: $107.7 thousand | Q3 2013: $163.7 thousand | Q1 2014: $2.63 million | Q2 2014: $3.01 million | Q3 2014: $1.86 million | Q1 2015: $2.71 million | Q2 2015: $2.41 million | Q3 2015: $4.15 million | Q1 2016: $2.42 million | Q2 2016: $2.49 million | Q3 2016: $2.94 million | Q1 2017: $3.76 million | Q2 2017: $4.08 million | Q3 2017: $5.59 million | Q1 2018: $8.07 million | Q2 2018: $12.35 million | Q3 2018: $13.60 million | Q1 2019: $14.91 million | Q2 2019: $16.85 million | Q2 2019: $16.85 million | Q3 2019: $12.60 million | Q3 2019: $12.60 million | Q1 2020: $8.27 million | Q1 2020: $8.27 million | Q2 2020: $5.40 million | Q3 2020: $5.56 million | Q1 2021: $4.84 million | Q2 2021: $5.13 million | Q3 2021: $5.11 million | Q1 2022: $4.45 million | Q2 2022: $4.14 million | Q3 2022: $3.75 million | Q1 2023: $4.15 million | Q2 2023: $3.97 million | Q3 2023: $4.09 million | Q1 2024: $4.00 million | Q2 2024: $3.95 million | Q3 2024: $3.87 million | Q1 2025: $3.61 million | Q2 2025: $3.62 million | Q3 2025: $3.26 million.
  • Historical annual values: Fiscal year 2025: $13.79 million | Fiscal year 2024: $15.71 million | Fiscal year 2023: $16.00 million | Fiscal year 2022: $16.21 million | Fiscal year 2021: $20.05 million | Fiscal year 2020: $24.43 million | Fiscal year 2019: $53.70 million | Fiscal year 2019: $53.70 million | Fiscal year 2018: $48.24 million | Fiscal year 2017: $20.68 million | Fiscal year 2016: $11.06 million | Fiscal year 2015: $11.53 million | Fiscal year 2014: $10.19 million | Fiscal year 2013: $2.15 million | Fiscal year 2012: $0.00.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: